Your browser doesn't support javascript.
loading
Isothiocyanates suppress the invasion and metastasis of tumors by targeting FAK/MMP-9 activity.
Jeong, Yun-Jeong; Cho, Hyun-Ji; Chung, Fung-Lung; Wang, Xiantao; Hoe, Hyang-Sook; Park, Kwan-Kyu; Kim, Cheorl-Ho; Chang, Hyeun-Wook; Lee, Sang-Rae; Chang, Young-Chae.
Affiliation
  • Jeong YJ; Research Institute of Biomedical Engineering and Department of Medicine, Catholic University of Daegu School of Medicine, Daegu 705-718, Republic of Korea.
  • Cho HJ; Research Institute of Biomedical Engineering and Department of Medicine, Catholic University of Daegu School of Medicine, Daegu 705-718, Republic of Korea.
  • Chung FL; Department of Neural Development and Disease, Korea Brain Research Institute (KBRI), Daegu 701-300, Republic of Korea.
  • Wang X; Department of Oncology, Lambardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA.
  • Hoe HS; Department of Oncology, Lambardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA.
  • Park KK; National Institutes of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Kim CH; Department of Neural Development and Disease, Korea Brain Research Institute (KBRI), Daegu 701-300, Republic of Korea.
  • Chang HW; Research Institute of Biomedical Engineering and Department of Medicine, Catholic University of Daegu School of Medicine, Daegu 705-718, Republic of Korea.
  • Lee SR; Department of Biological Science, Sungkyunkwan University, Suwon, Kyunggi-Do 440-746, Republic of Korea.
  • Chang YC; College of pharmacy, Yeungnam University, Gyeongsan 701-947, Republic of Korea.
Oncotarget ; 8(38): 63949-63962, 2017 Sep 08.
Article in En | MEDLINE | ID: mdl-28969043
ABSTRACT
Isothiocyanates, which are present as glucosinolate precursors in cruciferous vegetables, have strong activity against various cancers. Here, we compared the anti-metastatic effects of isothiocyanates (benzyl isothiocyanate (BITC), phenethyl isothiocyanate (PEITC), and sulforaphane (SFN)) by examining how they regulate MMP-9 expression. Isothiocyanates, particularly PEITC, suppressed 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced MMP-9 activity and invasion in various cancer cell lines. By contrast, N-methyl phenethylamine, a PEITC analog without an isothiocyanate functional group, had no effect. A reporter gene assay demonstrated that BITC, PEITC, and SFN suppressed TAP-induced MMP-9 expression by inhibiting AP-1 and NF-κB in U20S osteosarcoma cells. All three compounds reduced phosphorylation of FAK, ERK1/2, and Akt. In addition, MMP-9 expression was downregulated by inhibiting FAK, ERK1/2, and Akt. Isothiocyanates-mediated inhibition of FAK phosphorylation suppressed phosphorylation of ERK1/2 and Akt in U2OS and A549 cells, along with the translocation of p65 and c-Fos, suggesting that isothiocyanates inhibit MMP-9 expression and cell invasion by blocking phosphorylation of FAK. Furthermore, isothiocyanates, abolished MMP-9 expression and tumor metastasis in vivo with the following efficacy PEITC>BITC>SFN. Thus, isothiocyanates act as anti-metastatic compounds that suppress MMP-9 activity/expression by inhibiting NF-κB and AP-1 via suppression of the FAK/ERK and FAK/Akt signaling pathways.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncotarget Year: 2017 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncotarget Year: 2017 Document type: Article